Tag: #IronTherapy

Introduction Anemia is a common challenge for patients with End-Stage Renal Disease (ESRD), often requiring a combination of erythropoiesis-stimulating agents (ESAs) and intravenous (IV) iron therapy. The administration method of IV iron varies, and researchers continue to explore the most effective strategy. A recent study published in the Journal of Clinical Nephrology investigates the short-term…